Guidant Cautions Doctors on Defibrillators
From the Associated Press
Guidant Corp., which is being acquired for $27 billion by Boston Scientific Corp., cautioned doctors to check the voltage on certain implantable defibrillators after the company received reports of defective devices.
The Indianapolis medical device maker issued the warning for its Contak Renewal 3 RF and Contak Renewal 4 RF models of defibrillators, which shock the heart back to a normal rhythm.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
